✦ LIBER ✦

Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma

✍ Scribed by Niels Kroman; Helle Holtveg; Jan Wohlfahrt; Maj-Britt Jensen; Henning T. Mouridsen; Mogens Blichert-Toft; Mads Melbye

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 82 KB
Volume: 100
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20022

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND

Among middle‐aged and older women with early breast carcinoma, breast‐conserving therapy (BCT) has been shown to have an effect on survival that is similar to that of modified radical mastectomy (RM). Nonetheless, it remains to be established whether BCT also is the optimal treatment option for early breast carcinoma in young women, because these women generally have more aggressive disease and a higher frequency of local recurrence compared with older women.

METHODS

We investigated a cohort of 9285 premenopausal women with primary breast carcinoma who were age < 50 years at diagnosis. These women were identified from a population‐based Danish breast carcinoma database containing detailed information on patient and tumor characteristics, predetermined treatment regimens, and survival.

RESULTS

In total, 7165 patients (77.2%) were treated with RM, and 2120 patients (22.8%) were treated with BCT. We calculated the relative risk of death within the first 10 years after diagnosis according to surgical treatment and age, both before and after adjustment for known prognostic factors. No increased risk of death was observed among women who received BCT compared with women who underwent RM, regardless of age at diagnosis (< 35 years, 35–39 years, 40–44 years, or 45–49 years), despite the increased risk of local recurrence among young women. Restricting the analysis to women with small tumors (size < 2 cm) yielded similar results.

CONCLUSIONS

Despite having a higher rate of local recurrence, young women with breast carcinoma who receive BCT are similar to young women treated with RM in terms of survival. Cancer 2004;100:688–93. © 2003 American Cancer Society.

📜 SIMILAR VOLUMES

Eighteen-year results in the treatment o

Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy

✍ Brian K. P. Goh; Wei-Sean Yong 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

## Eighteen-Year Results in the Treatment of Early Breast Carcinoma with Mastectomy Versus Breast Conservation Therapy W e applaud the recent report by Poggi et al. 1 regarding the 18-year follow-up data of the National Cancer Institute randomized trial on breast conservation therapy (BCT) versus

Eighteen-year results in the treatment o

Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy : The National Cancer Institute randomized trial

✍ Matthew M. Poggi; David N. Danforth; Linda C. Sciuto; Sharon L. Smith; Seth M. S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract ## BACKGROUND Between 1979–1987, the National Cancer Institute conducted a randomized, prospective study of mastectomy (MT) versus breast conservation therapy (BCT) in the treatment of patients with early‐stage breast carcinoma. After a median potential follow‐up of 18.4 years, the aut

Effect of margins on ipsilateral breast

Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma

✍ Carson Leong; John Boyages; Upali W. Jayasinghe; Michael Bilous; Owen Ung; Boon 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

## Abstract ## BACKGROUND Breast conservative surgery (CS) with radiotherapy (RT) is the most commonly used treatment for early‐stage breast carcinoma. However, there is controversy regarding the importance of the pathologic margin status on the risk of ipsilateral breast tumor recurrence (IBTR).

A randomized trial of long term adjuvant

A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery

✍ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w

The effects of radiation therapy on qual

The effects of radiation therapy on quality of life of women with breast carcinoma : Results of a randomized trial

✍ Timothy J. Whelan; Mark Levine; Jim Julian; Peter Kirkbride; Peter Skingley; Ont 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## BACKGROUND. The purpose of this study was to evaluate the effect of breast irradiation on quality of life, including cosmetic outcome, for patients enrolled in a clinical trial. ## METHODS. Between 1984 and 1989, a randomized trial was conducted in Ontario, Canada, in which women with lymph no

Cost-effectiveness of switching to exeme

Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer

✍ Nancy A. Risebrough; Shailendra Verma; Maureen Trudeau; Nicole Mittmann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves disease‐free survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the cost‐effectiveness of switching to exemestane after 2 to